ERGOCALCIFEROL
DrugBank ID: db00153
DrugCentral: ergocalciferol
Synonymous :(3β,5z,7e,22e)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol | (5z,7e,22e)-(3s)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol | (5z,7e,22e)-(3s)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol | activated ergosterol | ercalciol | ergocalciférol | ergocalciferol | ergocalciferolum | oleovitamin d2 | viosterol | vitamin d2 | vitamina d2
Drug Sentece Context
Table 1. Analysis of context sentence of ergocalciferol gene in 1 abstracts.
| pmid | sentence |
|---|---|
| 32804682 | We report 4 vitamin D deficient patients diagnosed with COVID-19 in April 2020 who were provided with either cholecalciferol of 1000 IU daily (standard dose) or ergocalciferol 50,000 IU daily for 5 days (high dose) as part of supplementation. |
| 33005518 | The patient was started on 50,000 units of ergocalciferol once a week. |
| 33324234 | A search using the search terms: [(cholecalciferol or ergocalciferol or vitamin D2 or vitamin D3 or vitamin D or 25OHD) and (SARS-CoV-2 or coronavirus or COVID or betacoronavirus or MERS-CoV or SARS-CoV or respiratory infection or acute respiratory distress syndrome or ARDS)]m.p. was conducted on the 24/04/2020 (Search A) and 17/09/2020 (Search B). 91 studies were identified as being concerned with Acute Respiratory Infection (ARI)/Acute Respiratory Distress Syndrome (ARDS) and vitamin D, and 25 publications specifically explored the role of vitamin D deficiency in the development and progression of SARS-CoV-2/COVID-19 related ARDS. |